http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2095127-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce023a6c13740cb05a67332f11a29f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-43
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43
filingDate 1991-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d97c15fe4776ae651e2d2a7b32698c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73fe70136902ce353b2040fbec4df27
publicationDate 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2095127-C
titleOfInvention Process for improving flow characteristics of crystalline ibuprofen
abstract A process for producing crystalline ibuprofen having a crystal habit characteriz ed by a particle length larger than 75 microns average and a length to width aspect ratio of greater than about 4 to 1 to about 5 to 1. The process involves crystallizing ibuprofen from a saturated solution of ibuprofen in a liquid hydrocarbon solvent by seeding and cooling such solution to a temperature of about 0 .degree.C to about -20 .degree.C at a rate to retard prim ary nucleation and promote secondary nucleation. The crystalline ibuprofen is separated from the slurry produced from such cooling.
priorityDate 1990-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5338317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420932897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451894263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502717

Total number of triples: 34.